Agenda Preliminar

16:00 - 16:15Opening Session: Welcome and Agenda Review 
16:15 - 16:45Opening lecture: The Future of Obesity and MASLD Management in Diabetes CareCarel Le Roux, MBChB, MSC, FRCP, FRCPath, PhD, UCD Conway Institute, University College Dublin, Ireland
16:45 - 17:00Q&A 
17:00 - 17:20GLP-1 and Dual Agonists: Choosing the Right Patient, the Right Drug for ObesityDr. Juan Pablo Frías, Instituto de Investigación Metabólica de Los Ángeles, Los Ángeles, California, Estados Unidos
17:20 - 17:40MASLD in People with Diabetes: Screening and Treatment in Daily PracticeHelena Cortez-Pinto, MD, PhD, FAASLD, Faculdade de Medicina, Universidade de Lisboa (FMUL), Portugal
17:40 - 18:00For debate: Should MASLD Be Managed Primarily by Diabetologists or Hepatologists?Josep Vidal, MD, Hospital Clínic, Spain
Dr. Manuel Romero-Gómez, Universidad de Sevilla, Andalucía, España
18:00 - 18:15Q&A 
18:15 - 18:45Coffee break 
18:45 - 19:05New Evidence for Cardiovascular Outcomes with GLP-1 and Dual AgonistsMelanie Davies, Leicester General Hospital, UK
19:05 - 19:25Beyond Glycemia: Kidney Protection with SGLT2 Inhibitors and Combination TherapyJosé Luis Górriz, MD, Valencian Society of Nephrology, Spain
19:25 - 19:45Sex Differences and Personalized Risk Stratification in Cardio-Renal DiseaseEmilio Ortega, MD, Hospital Clínic, Spain
19:45 - 20:00Q&A 
20:00 - 20:15Current Challenges of Management of Diabetes in Portugal and Spain: Portugal’s PerspectiveJoão Filipe Raposo, MD, PhD, SPD – Portuguese Diabetes Society, Portugal
20:15 - 20:30Current Challenges of Management of Diabetes in Portugal and Spain: Spain’s PerspectiveAntonio Pérez, MD, PhD, Hospital de la Santa Creu i Sant Pau, Spain
20:30 - 20:45Open Discussion 
20:45 - 21:00Day 1 Summary and Closing Remarks 
8:10 - 8:55Breakfast Symposium 
8:55 - 9:00Welcome Day 2  
9:00 - 9:20Closed-Loop Systems in 2025: Are We Truly at the Fully Automated Era?Jorge Bondia, Professor, Universitat Politècnica de València, Spain
9:20 - 9:40Beyond Glucose: Ketone, Insulin, and Multimarker Continuous MonitoringKetan Dhatariya, Prof, MD, Norfolk & Norwich University Hospital, UK
9:40 - 10:00For Debate: Time in Tight Range (TIR) vs. HbA1c: Which Should Be the Primary Treatment Goal?Pilar Beato, MD, PhD, Badajoz University Hospital, Spain
Elías Delgado, MD, Universidad de Oviedo, Spain
10:00 - 10:15Q&A 
10:15 - 10:45Workshop 1: From Data to Decisions: Hands-On with Digital Tools in DiabetesCintia González, MD, Hospital de la Santa Creu i Sant Pau, Spain
10:15 - 10:45Workshop 1: Designing the Right Meal Plan: Tailoring Nutrition to Real-World PatientsSerafín Murillo, MD, PhD, Hospital Sant Joan de Déu, Spain
10:45 - 11:15Coffee Break 
11:15 - 11:35Population Screening for Type 1 Diabetes: Practical Lessons from EuropeAnette-Gabriele Ziegler, Prof. Dr., med., Klinikum rechts der Isar, Technische Universität München, School of Medicine, Germany
11:35 - 11:55Immunotherapy in Early T1D: Where Do We Stand After Teplizumab?Johnny Ludvigsson, MD, PhD, Linköping University, Sweden
11:55 - 12:15Lifestyle, Microbiome, and Environmental Factors: Can We Modify the Risk?Mikael Knip, MD, PhD, University of Helsinki, Finland
12:15 - 12:30Q&A 
12:30 - 13:00Workshop 2: From Data to Decisions: Hands-On with Digital Tools in DiabetesCintia González, MD, Hospital de la Santa Creu i Sant Pau, Spain
12:30 - 13:00Workshop 2: Designing the Right Meal Plan: Tailoring Nutrition to Real-World PatientsSerafín Murillo, MD, PhD, Hospital Sant Joan de Déu, Spain
13:00 - 13:30Keynote lecture - Towards Precision Diabetes Medicine: Integrating Genetics, Technology, and TherapiesAndrew Hattersley, Prof. Dr., med., University of Exeter, UK
13:30 - 13:45Q&A 
13:45 - 14:00Adjourn 
Zona horaria: (UTC+02:00) Madrid [Cambiar zona horaria]